Related Experiment Video

Updated: Feb 26, 2026

C-arm-Free Simultaneous OLIF51 and Percutaneous Pedicle Screw Fixation in a Single Lateral Position
12:25

C-arm-Free Simultaneous OLIF51 and Percutaneous Pedicle Screw Fixation in a Single Lateral Position

Published on: September 16, 2022

4.7K

[Prescription pattern in the management of Type I open forearm fractures in pediatric patients]

J A López-Tello1, B J Torres-Fernández1, N G Escalona-Reynoso2

  • 1Unidad Médica de Alta Especialidad (UMAE), Hospital de Traumatología y Ortopedia «Dr. Victorio de la Fuente Narváez» del Instituto Mexicano del Seguro Social (IMSS). Av. Colector 15 s/n (Eje Fortuna) casi Esq. Av. Instituto Politécnico Nacional, Col. Magdalena de las Salinas, CP 07760, Del. Gustavo A. Madero, Ciudad de México, México.

Acta Ortopedica Mexicana
|July 26, 2017
PubMed

Insights

Surgical management is common for pediatric Type I open forearm fractures. While certain treatments were linked to reoperation, they did not significantly affect hospital stay duration in this study.

Area of Science:

  • Orthopedic Surgery
  • Pediatric Trauma
  • Fracture Management

Background:

  • Pediatric open fractures represent over 10% of admissions in trauma centers.
  • Understanding surgical management patterns for Type I open forearm fractures in children is crucial, especially in emerging economies.

Purpose of the Study:

  • To identify the predominant surgical management strategies for Type I open forearm fractures in pediatric patients.
  • To analyze the association between surgical methods and outcomes like reoperation and hospital stay.

Main Methods:

  • An observational, cross-sectional study analyzed data from pediatric patients under 17 with Type I open forearm fractures.
  • Data was collected from clinical logs between January 2009 and December 2013.

Main Results:

  • Ninety-two pediatric patients with Type I open forearm fractures were included.
  • All patients received antibiotics and surgical debridement. Casts (75%) were the most common fixation method, followed by Kirschner nails (10%) and ORIF (5.4%).
  • Nine percent of patients required reoperation.

Conclusions:

  • Surgical management is the predominant approach for pediatric Type I open forearm fractures.
  • The chosen surgical method was associated with the need for a second surgery, but not hospital stay length.
Abstract

Keywords:
Open fracturechildprescriptiontreatment

More Related Videos

Treatment with Locking Intramedullary Nailing for Intertrochanteric Fracture of the Femur Utilizing a New Awl with a Distal Positioner04:41

Treatment with Locking Intramedullary Nailing for Intertrochanteric Fracture of the Femur Utilizing a New Awl with a Distal Positioner

Published on: June 6, 2025

1.3K
Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device04:19

Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device

Published on: November 8, 2024

1.5K

Related Concept Videos

Fractures: Bone Repair01:27

Fractures: Bone Repair

Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
5.9K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
400
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
732
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
332
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
377
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289